Management
Team

Rémi DANGLA, PhD

CEO, co-founder and inventor of the technology

Named as Top 10 Biotech entrepreneur under 30 in 2016 by Labiotech.eu.
Named as Top 10 French Innovator Under 35 by MIT Technological Review in 2014.
Co founded Stilla Technologies in 2013 to build a disruptive digital PCR solution, using the microfluidic technologies he helped establish.
Started his career in 2009 at the laboratory LadHyx of Ecole Polytechnique, exploring new approaches in droplet microfluidics for easy integration into innovative commercial products.

Director of Business Development

15-years experience in Life Sciences start-ups in North America and Europe (Qiagen, Bio-K+, Nextal Biotechnologies).
Joined Stilla in 2016 convinced that a well designed product, a booming market and a great team are Stilla’s ingredients for commercial success.
Graduated from HEC Montreal (MSc in Management in Technological Entrepreneurship).

Director of Product developement

Joined Stilla in 2014 as co-founder and used his advanced knowledge about Stilla’s core technology to design and build Stilla’s Naica System with his team of engineers.
Completed his PhD in fluid mechanics at Ecole Polytechnique.
Graduated at Ecole Centrale Paris, and got also a MA degree in Applied Mathematics at Cambridge University.

Chief Financial Officer (CFO)

Ensures that Stilla has the financial ressources required for its fast development and supports Caroline Charky in business development.
Joined Stilla as co-founder in 2013.
Gratuated from HEC Paris (Major in Entrepreneurship).

Director of Applications

More than 10-year experience in molecular Biology.
Early on, Magali ran proof-of-concept crystal dPCR experiments using early-stage prototypes. She is now dedicated to demonstrating the full potential of the Naica System.
Magali has a PhD in Biological Sciences from the University of Warwick (UK) and completed her postdoctoral training at UCLA as a molecular virologist.